Library

BDCK

Potency approximately 0.5-0.7× racemic ketamine by weight; larger lines are often required, increasing nasal irritation. Subjectively described as warm, euphoric, and floaty with weaker dissociation than ketamine and a noticeably shorter plateau. Limited human data; virtually all knowledge comes from small animal studies and user reports. Exercise conservative dosing, weigh milligram-accurately, allow 2 hours between redoses to reduce cumulative toxicity. BDCK was used as an NMDA-antagonist control compound in antidepressant research.

BDCK molecular structure
BDCK molecular structure diagram from the DrugsPRO substance library.

Also known as: 2-bdck, 2-br-dck, 2-br-2'-oxo-pcm, 2-bromodeschloroketamine, Bromoketamine, Bromo‑DCK

Classification

  • Chemical: Arylcyclohexylamine
  • Psychoactive: Depressant
  • Psychoactive: Dissociative
  • Tag: Hallucinogen
  • Tag: Research-Chemical

Effects

  • Pain Relief
  • Physical Disconnection
  • Somatic Lightness
  • Incoordination
  • Impaired Balance
  • Nystagmus
  • Physical Autonomy
  • Time Distortion
  • Cognitive Disconnection
  • Euphoria
  • Conceptual Thinking
  • Motor Control Loss
  • Bodily Lightness
  • Spatial Disorientation
  • Closedeye Visuals
  • Double Vision
  • Vibrating Vision
  • Increased Music Appreciation

Routes of Administration

Insufflated

Dosage

  • Threshold: 20-30 mg
  • Light: 40-70 mg
  • Common: 70-130 mg
  • Strong: 130-220 mg
  • Heavy: 250+ (↑ nasal damage risk) mg

Duration

  • Onset: 0.08-0.25 h
  • Comeup: 0.17-0.33 h
  • Peak: 0.5-1 h
  • Offset: 0.75-1.5 h
  • After Effects: 1.8-3 h
  • Total Duration: 1-2.5 h

Intramuscular

Dosage

  • Threshold: 0.3 mg/kg
  • Light: 0.5 mg/kg
  • Common: 0.7–1.0 mg/kg
  • Strong: 1.0–1.2 mg/kg
  • Heavy: 1.2+ mg/kg

Duration

  • Onset: 0.03-0.08 h
  • Comeup: 0.08-0.25 h
  • Peak: 0.5-1 h
  • Offset: 0.75-1.5 h
  • After Effects: 1-3 h
  • Total Duration: 1.5-3 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

BDCK - Guida alle sostanze DrugsPRO

BDCK: Potency approximately 0.5-0.7× racemic ketamine by weight; larger lines are often required, increasing nasal irritation. Subjectively described as warm, euphoric, and floaty with weaker dissociation than ketamine and a noticeably shorter plateau. Limited human data; virtually all knowledge com

Related pages